Bextra


Also found in: Dictionary, Medical.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for Bextra

a Cox-2 inhibitor (trade name Bextra) that relieves pain and inflammation without harming the digestive tract

Synonyms

Related Words

References in periodicals archive ?
95 billion criminal penalty specifically for its off-label marketing of the drug Bextra, at the time the largest criminal fine in U.
Pfizer's $1 billion civil penalty is to resolve civil allegations of illegally promoting three other drugs in addition to Bextra drugs--Geodon, an anti-psychotic drug; Zyvox, an antibiotic; and Lyrica, an anti-epileptic drug.
Bextra, an arthritis drug, was withdrawn from the market in 2005 over safety concerns.
But Pfizer marketed Bextra for those unapproved uses anyway," he said.
News_ID=268328262&testosterone bextra http://www2.
FDA action on two painkillers, Bextra and Vioxx, shows the pharmaceutical companies' influence on the drug-approval process.
For instance, Pitruzzello pointed to the withdrawl of such cox-2-inhibiting nonsteroidal anti-inflammatory drugs as Vioxx and Bextra.
And physicians are becoming more leery of thinking that every new drug represents a 'breakthrough' or improvement over existing therapies--something that resulted in part from the problems around Vioxx and Bextra," she said.
At Pfizer's request, FDA then took the Bextra material off its website and reposted it several months later, after redacting information about use of the drug for acute pain.
This past year, Celebrex and Bextra, in the same class as Vioxx, made headlines for their adverse effects; and in February, sales of the multiple sclerosis drug Tysabri were suspended after it was suspected of triggering a rare brain disease in three patients, two of whom died from the disease.
Not unexpectedly, sales declines were most dramatic for brands specifically cited in FDA questioning--Vioxx, Celebrex, Bextra, and Naproxen (Aleve).
s Bextra and Celebrex and the O-T-C medication Aleve from Bayer Corp.
The health-care and drugs firm's profit was helped by increased revenues from its treatments for arthritis: Sales of Mobic tripled after Bextra, a rival drug from Pfizer, was withdrawn on safety grounds.
The recent FDA withdrawals of Vioxx and Bextra are prompting many consumers to search out safe alternatives for coping with arthritis and chronic back pain.
Senate Bill 1011 would apply only to people who used a "Cox 2 inhibitor" drug, such as Vioxx or Bextra, which was recalled from the market by its manufacturer, Pfizer.